Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1525

    1.

    Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus.

    Ceglia L, Lau J, Pittas AG.

    Ann Intern Med. 2006 Nov 7;145(9):665-75.PMID: 17088580 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial.

    Rosenstock J, Zinman B, Murphy LJ, Clement SC, Moore P, Bowering CK, Hendler R, Lan SP, Cefalu WT.

    Ann Intern Med. 2005 Oct 18;143(8):549-58.PMID: 16230721 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Insulin glargine: a systematic review of a long-acting insulin analogue.

    Wang F, Carabino JM, Vergara CM.

    Clin Ther. 2003 Jun;25(6):1541-77, discussion 1539-40. Review.PMID: 12860485 [PubMed - indexed for MEDLINE]Related articles

    4.

    Inhaled insulin in diabetes mellitus.

    Royle P, Waugh N, McAuley L, McIntyre L, Thomas S.

    Cochrane Database Syst Rev. 2003;(3):CD003890. Review. Update in: Cochrane Database Syst Rev. 2004;(3):CD003890. PMID: 12917994 [PubMed - indexed for MEDLINE]Related articles

    5.

    Inhaled insulin in diabetes mellitus.

    Royle P, Waugh N, McAuley L, McIntyre L, Thomas S.

    Cochrane Database Syst Rev. 2004;(3):CD003890. Review. Update in: Cochrane Database Syst Rev. 2009;(1):CD003890. PMID: 15266506 [PubMed - indexed for MEDLINE]Related articles

    6.

    WITHDRAWN: Inhaled insulin in diabetes mellitus.

    Royle P, Waugh N, Deakin M, Philip S.

    Cochrane Database Syst Rev. 2009 Jan 21;(1):CD003890. Review.PMID: 19160227 [PubMed - indexed for MEDLINE]Related articles

    7.

    Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis.

    Amori RE, Lau J, Pittas AG.

    JAMA. 2007 Jul 11;298(2):194-206. Review.PMID: 17622601 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Inhaled human insulin.

    Strack TR.

    Drugs Today (Barc). 2006 Apr;42(4):207-21. Review.PMID: 16703118 [PubMed - indexed for MEDLINE]Related articles

    9.

    Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.

    Siebenhofer A, Plank J, Berghold A, Narath M, Gfrerer R, Pieber TR.

    Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003287. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD003287. PMID: 15495047 [PubMed - indexed for MEDLINE]Related articles

    10.

    Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.

    Siebenhofer A, Plank J, Berghold A, Narath M, Gfrerer R, Pieber TR.

    Cochrane Database Syst Rev. 2004;(2):CD003287. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD003287. PMID: 15106199 [PubMed - indexed for MEDLINE]Related articles

    11.

    Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes.

    Qayyum R, Bolen S, Maruthur N, Feldman L, Wilson LM, Marinopoulos SS, Ranasinghe P, Amer M, Bass EB.

    Ann Intern Med. 2008 Oct 21;149(8):549-59. Epub 2008 Sep 15. Review.PMID: 18794553 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

    Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

    Ann Intern Med. 2008 Oct 21;149(8):531-9.PMID: 18936501 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial.

    Quattrin T, Bélanger A, Bohannon NJ, Schwartz SL; Exubera Phase III Study Group.

    Diabetes Care. 2004 Nov;27(11):2622-7.PMID: 15504996 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Managed care perspective on three new agents for type 2 diabetes.

    VanDeKoppel S, Choe HM, Sweet BV.

    J Manag Care Pharm. 2008 May;14(4):363-80. Review.PMID: 18500914 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Addition of thiazolidinedione or exenatide to oral agents in type 2 diabetes: a meta-analysis.

    Pinelli NR, Cha R, Brown MB, Jaber LA.

    Ann Pharmacother. 2008 Nov;42(11):1541-51. Epub 2008 Oct 28.PMID: 18957626 [PubMed - indexed for MEDLINE]Related articles

    16.

    Treatment satisfaction in type 2 diabetes: a comparison between an inhaled insulin regimen and a subcutaneous insulin regimen.

    Cappelleri JC, Cefalu WT, Rosenstock J, Kourides IA, Gerber RA.

    Clin Ther. 2002 Apr;24(4):552-64.PMID: 12017400 [PubMed - indexed for MEDLINE]Related articles

    17.

    Inhaled human insulin treatment in patients with type 2 diabetes mellitus.

    Cefalu WT, Skyler JS, Kourides IA, Landschulz WH, Balagtas CC, Cheng S, Gelfand RA; Inhaled Insulin Study Group.

    Ann Intern Med. 2001 Feb 6;134(3):203-7.PMID: 11177333 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes.

    Rosenstock J, Cappelleri JC, Bolinder B, Gerber RA.

    Diabetes Care. 2004 Jun;27(6):1318-23.PMID: 15161782 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review.

    DeWitt DE, Hirsch IB.

    JAMA. 2003 May 7;289(17):2254-64. Review.PMID: 12734137 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data